XML 27 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814
JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) - USD ($)
9 Months Ended 38 Months Ended
Aug. 03, 2012
Sep. 30, 2015
Sep. 30, 2015
Related Party Transaction [Line Items]      
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures $ 6,000,000 $ 6,000,000 $ 6,000,000
Joint Venture Investments In Voting Common Ownership Units (in shares) 600,000    
Joint Venture Method Investment Ownership Percentage 60.00%    
Joint Venture Investments In Non Voting Preferred Ownership Units 5,000,000    
Joint Venture Investments Common Ownership Units, Co-venture (in shares) 400,000    
Ownership Percentage Co-venture 40.00%    
Percentage Of Royalty Payment 3.00%    
Development Activities Monthly Fee $ 63,000    
Accounting and Administrative Monthly Fee $ 1,000    
Joint Venture, Operating Expenses, Inter Company Transactions   503,000 6,738,000
Joint Venture, Operating Expenses Allocated To Company   503,000 6,071,000
Percentage Of Non Royalty Income 5.00%    
Reduced Monthly Management Fee $ 35,000    
Revolving Credit Facility [Member]      
Related Party Transaction [Line Items]      
Line of Credit Facility, Maximum Borrowing Capacity   700,000 700,000
Long-term Line of Credit   759,000 759,000
Common Stock [Member]      
Related Party Transaction [Line Items]      
Joint Venture Losses Recognition Criteria, Common Ownership Equity   $ 0 $ 0
Noncontrolling Interest, Ownership Percentage by Parent   60.00% 60.00%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners   40.00% 40.00%
Preferred Stock [Member]      
Related Party Transaction [Line Items]      
Noncontrolling Interest, Ownership Percentage by Parent   100.00% 100.00%
Exclusive License Agreement [Member]      
Related Party Transaction [Line Items]      
Annual Maintenance Payments 25,000    
Exclusive License Agreement [Member] | Maximum [Member]      
Related Party Transaction [Line Items]      
Milestone Payments 500,000    
Royalty Expense 1,000,000    
Exclusive License Agreement [Member] | Minimum [Member]      
Related Party Transaction [Line Items]      
Milestone Payments 50,000    
Royalty Expense 500,000    
Lipimetix [Member]      
Related Party Transaction [Line Items]      
Noncash or Part Noncash Acquisition, Other Liabilities Assumed   $ 667,000  
Voting Common Ownership Units [Member]      
Related Party Transaction [Line Items]      
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures 1,000,000    
Non Voting Preferred Ownership Units [Member]      
Related Party Transaction [Line Items]      
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures $ 5,000,000